These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7937406)

  • 1. [Functional mechanism of antisense oligodeoxyribonucleotides].
    Szklarczyk A
    Postepy Biochem; 1994; 40(3):166-74. PubMed ID: 7937406
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligodeoxynucleotide analogs as informational drugs to regulate translation.
    Ghosh M; Ghosh K; Cohen JS
    Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro suppression of translation of tick-borne encephalitis virus RNA using antisense nucleotides].
    Nomokonova NIu; Gorn VV; Vlasov VV
    Mol Biol (Mosk); 1993; 27(2):327-34. PubMed ID: 8487765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
    Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current antisense nucleic acid strategies for manipulating neuronal and glial cells.
    Eng LF
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():293-310. PubMed ID: 8417469
    [No Abstract]   [Full Text] [Related]  

  • 7. Oligodeoxynucleotide inhibitors of function: mRNA and protein interactions.
    Neckers LM
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S35-42. PubMed ID: 9619269
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
    Delihas N; Rokita SE; Zheng P
    Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific antisense oligodeoxynucleotide to mRNAs encoding receptors with seven transmembrane spanning regions decreases muscarinic m2 and gamma-aminobutyric acidB receptors in rat cerebellar granule cells.
    Holopainen I; Wojcik WJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):423-30. PubMed ID: 8380868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides.
    Kronenwett R; Gräf T; Nedbal W; Weber M; Steidl U; Rohr UP; Möhler T; Haas R
    Cancer Gene Ther; 2002 Jul; 9(7):587-96. PubMed ID: 12082459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic AMP-triggered aromatase gene expression in human choriocarcinoma cells by antisense oligodeoxynucleotide.
    Ackermann K; Fauss J; Pyerin W
    Cancer Res; 1994 Sep; 54(18):4940-6. PubMed ID: 8069860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suppression of influenza virus NP-protein mRNA translation in vitro with derivatives of an antisense oligonucleotide].
    Abramova TV; Vlasov VV; Ivanova EM; Zarytova VF; Fokina TN; Frolova EI; Iurchenko LV
    Mol Biol (Mosk); 1994; 28(2):307-12. PubMed ID: 8183262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme.
    Denman RB; Smedman M; Abraham M; Chen-Hwang MC; Currie JR
    Arch Biochem Biophys; 1997 Dec; 348(1):82-90. PubMed ID: 9390177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5' untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers.
    Yang D; Wilson JE; Anderson DR; Bohunek L; Cordeiro C; Kandolf R; McManus BM
    Virology; 1997 Feb; 228(1):63-73. PubMed ID: 9024810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative translation start sites and hidden coding potential of eukaryotic mRNAs.
    Kochetov AV
    Bioessays; 2008 Jul; 30(7):683-91. PubMed ID: 18536038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antisense technology: overview and bridged nucleic acid analogs].
    Imanishi T
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1616-24. PubMed ID: 12931621
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of reproduction of the human immunodeficiency virus by sense and antisense oligodeoxynucleotides].
    Pokrovskiĭ AG; Pliasunova OA; Blinov VM; Vlasov VV; Svinarchuk FP; Abramova TV; Gorn VV; Konevets DA
    Mol Biol (Mosk); 1993; 27(5):1039-43. PubMed ID: 8246927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.